Here's Jim Cramer's advice on McDonald's stock after its third downgrade in a week

McDonald's stock is facing increased scrutiny from Wall Street, with Redburn Atlantic issuing a double downgrade to 'sell' and a price target of $260, citing concerns that GLP-1 weight loss drugs pose a significant threat to fast-food demand; this follows downgrades from Morgan Stanley and Loop Capital due to softening traffic among key consumer groups and negative feedback on recent menu items. Despite these concerns, Jim Cramer is urging investors to buy McDonald's, expressing confidence in CEO Chris Kempczinski's ability to adapt and overcome these challenges, viewing the downgrades as an overreaction.

Analysis

McDonald's Corporation (MCD) is confronting heightened skepticism from Wall Street, as evidenced by three analyst downgrades within a single week, contributing to a roughly 4% decline in its stock price in June, underperforming the S&P 500's approximate 2% gain during the same period. Redburn Atlantic delivered a 'double downgrade' to sell, setting a $260 price target (nearly 15% below Monday's close), citing the "underappreciated longer-term threat" of GLP-1 weight loss drugs suppressing appetite and altering consumer behavior. This follows downgrades to hold-equivalent ratings from Morgan Stanley (price target $324 from $329) and Loop Capital (price target $315 from $346). Loop Capital's concerns stem from potentially weaker-than-expected same-store sales growth in 2025 due to two quarters of softening traffic among lower- and middle-income consumers, and "predominantly negative customer feedback" on its recent chicken strip launch, potentially impacting the upcoming snack wrap introduction. In contrast, Jim Cramer advocates buying MCD, expressing strong confidence in CEO Chris Kempczinski's leadership to address these issues and dismissing the analyst concerns as an overreaction, viewing the current situation as a buying opportunity.

Key Decisions for Investors

• Investors should carefully weigh the recent spate of analyst downgrades for McDonald's, which cite fundamental headwinds such as the impact of GLP-1 drugs, softening traffic from core consumer segments, and initial negative feedback on new product launches, against the stock's current underperformance.
• Key performance indicators to monitor closely include upcoming same-store sales data, reports on consumer traffic trends, and the market reception of new menu items, which will be critical in assessing the company's ability to navigate these challenges.
• Acknowledge the contrarian perspective offered by Jim Cramer, which banks on strong leadership and brand resilience, suggesting that current weakness could present a buying opportunity for those with a higher risk tolerance or a belief in management's ability to adapt effectively.